BIOMILQ is a women-owned and science-led start-up building a mammary biomanufacturing platform to produce bioauthentic human milk ingredients for better human health. By combining the unique capabilities of human mammary cells with a scalable biomanufacturing process, BIOMILQ aims to demonstrate the power of our platform through impact in early-life nutrition with ingredients that promote immune, gut, and neurological development.

Michelle Egger

Leila Strickland

BIOMILQ

BIOMILQ is a women-owned and science-led mammary biotechnology start-up leveraging its patented technology to produce functional cell-cultured human milk components outside the body. With the goal of bridging the gap between breast milk and infant formula, BIOMILQ aims to revolutionize early-life nutrition by bringing more of the benefits of breast milk to more babies.

Blue Horizon Corporation

Breakthrough Energy Ventures

Purple Orange Ventures

Shazi Visram

Spero Ventures

Digitalis Ventures

Novo Holdings

Gaingels

Green Generation Fund

Alexandria

We're #hiring!

If you're passionate about early life nutrition, women's empowerment, and sustainability, click the link below to apply for one of our open positions:

- Research Associate (Temp)
- People Operations (HR) Manager

BIOMILQ is proud to have been named a Family Forward NC Certified Employer by the North Carolina Early Childhood Foundation’s Family Forward NC initiative. A Family Forward NC Employer Certification designates employers that offer policies and practices that support the health and well-being of working families and children.

https://lnkd.in/gKPXfPDC
#hiringopportunity

The BIOMILQ team recently stepped away from the world of mammary biotechnology to explore the city we're headquartered in: Durham, North Carolina!
 
We immersed ourselves in the heart of Durham through a food and walking tour. From savoring soul food to ice cream and everything in between, we had the perfect kick-off to the festive season. 
 
Each stop on the tour unfolded unique narratives as we listened to the local restaurant owners share their stories behind building their businesses. This served as a powerful source of inspiration for our team as we gear up for the new year's opportunities! 
 
We're thankful for a team that embraces new adventures, has fun while doing it, and appreciates good food. 
 
Happy holidays from the BIOMILQ team!

Our CEO and co-founder, Leila Strickland, PhD, was recently a part of The Wall Street Journal's latest Future of Everything podcast hosted by Alex Ossola. 
 
Breast milk has long been known as the gold standard of #infantnutrition, as it brings a plethora of nutritional and functional benefits to rapidly growing and developing babies. However, the fact stands that the majority of babies are not receiving the recommended exposure to breast milk – and we know that is not from a lack of trying from caretakers (to list a few reasons as to why someone may not be able to breastfeed: lack of parental leave, lack of familial support, low milk supply, latching issues, food allergies, adoptive families, and many many more). 
 
Early life nutrition products are facing an unmet need for premium ingredients that bring the nutritional profile of their products closer to breast milk. By utilizing the unique potential of human mammary cells and #cellculture technology, BIOMILQ is working to produce functional human milk components to nourish healthier babies and bring more of the functional benefits of breast milk to early life nutrition products. 
 
Human mammary cells have the potential to produce many types of developmentally beneficial bioactive components that cannot be produced from other cell types or other scientific methods – and we cannot wait to share with you what we envision as BIOMILQ's first components! 
 
Click the link below to listen to how BIOMILQ and some of our industry peers are working to advance human nutrition.
 
https://lnkd.in/gesJqgCA
#wsj #futureofeverything #infatnnutrition #cellculturetechnology

BIOMILQ is a winner of the 2023 World Cell-Based Innovation Awards! Huge thank you to The Cell Base and FoodBev Awards, and congratulations to all the winners Umami Bioworks, C16 Biosciences, BioBetter™, Senara GmbH, The Cultivated B, and TissenBioFarm!

And that’s a wrap for conferences in 2023! Big thank you to the Asia-Pacific Agri-Food Innovation Summit, Agri-Food Tech Expo Asia and their teams for putting together a wonderful week of events in Singapore. One I would love to highlight is the Women in Food and AgTech event hosted by Brian Frank FTW Ventures in partnership with Foodbytes by Rabobank, Thai Wah Ventures, Gullspång Re:food, Enterprise Singapore, and Wendy Chng Petit with Agri-Food Tech Expo Asia. It was incredible to meet with so many people in Asia who are passionate about supporting female-founded companies like BIOMILQ. I'm hoping to see more events like these in 2024.

When The Good Food Institute and the APAC Society for Cellular Agriculture announced the APAC Regulatory Coordination Forum and their MOU last week, Good Food Institute APAC Managing Director Mirte Gosker said, “The location of this historic announcement was no coincidence. In recent years, Singapore has invested the necessary resources to make the city-state a welcoming ecosystem for food innovation and multilateral collaboration. This MOU is the latest proof that the Lion City is trading its traditional reliance on food imports for a new role as the place where the alternative protein sector’s biggest decisions are forged, announced, and exported to the world.”

Love to see countries like Singapore that have created a welcoming system for food innovation and companies like BIOMILQ, and we hope to see you again in Singapore in 2024!

Having an inspiring week in Singapore at the Asia-Pacific Agri-Food Innovation Summit and Agri-Food Tech Expo Asia. One of my favorite panels so far was on meeting nutritional needs in Asia. Moderated by Gary Scattergood with Yanjing Wang, Corine Tap, Jeya Henry, and Weitze Ooi: there was a big focus on early life nutrition, and how they are prioritizing innovation and access for new, nutritious food products for the younger generations throughout Asia. When asked about the future, Corine Tap noted: "having a good start in life for children with access to the right nutrition is essential for the next generations to thrive, and there is still a lot of work to be done." BIOMILQ couldn't agree more. 

It has been incredible to hear from so many investors, strategic partners, and companies from all sectors throughout Asia who support BIOMILQ's mission. Please feel free to reach out to learn more about us if I didn't get to a chance to meet you yet!

Recently, we've collaborated on a project with one of our neighbors in Research Triangle Park, Tiamat Sciences Corp.
 
Read below how BIOMILQ and Tiamat Sciences Corp. demonstrated the potential of a plant-based recombinant protein, Human Prolactin, as a cost-effective alternative in the biotechnology industry. This project presents exciting opportunities for scalability in the cell-based food industry where cell culture media is a huge cost driver.

#plantbased #cellbased #biotech 

https://lnkd.in/g3nY4KaA

We're so glad that our Senior Director of Business Development, Amy Kiska, has been representing BIOMILQ these last few weeks and meeting incredible peers along the way. 

Next stop: Asia-Pacific Agri-Food Innovation Summit in Singapore!

Recently our CEO and co-founder, Leila Strickland, PhD, and two of BIOMILQ's team leads, Victoria Slaughter and Zack Holmes, PhD, attended the International Milk Genomics Consortium Symposium (IMGC) in Ireland! 

IMGC is an annual symposium that features the most cutting-edge research and discoveries in milk science and its applications for human health. 

This was BIOMILQ's 3rd year attending the symposium. This time around, we presented two scientific posters on some of our latest research, and Leila Strickland, PhD gave a scientific talk highlighting the benefits of our mammary-based production platform compared with alternative technologies. 

With worldwide attendance from the leaders moving milk forward in academia and industry, BIOMILQ has returned from the symposium energized by new ideas and a growing list of collaborations that will guide our strategy going forward.  

Click the link below to read about BIOMILQ's experience at IMGC: 

https://lnkd.in/grMT7Pk3

National Breastfeeding Month is for everyone - whether you breastfeed, pump, formula feed, or anything in between! 

Click the link below to read our latest article on Infant Feeding Practices and National Breastfeeding Month.

https://lnkd.in/ghYFMgWD

Metric
Company Name	BIOMILQ
Symbol
MSH ID	COM:BIOMILQ
Market	PRIVATE
Sector	Healthcare
Industry	Biotechnology
Country	US
Stage
Employee Count	28
Website	biomilq.com
LinkedIn	biomilq
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:BIOMILQ

BIOMILQ

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue